Psychedelics Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products April 20, 2026
Psychedelics Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering March 16, 2026
Search
medication
April 20, 2026
March 16, 2026
